Introduction Reports on the haemodynamics of intravenous (iv) paracetamol in adult intensive care were recently published. We therefore wanted to explore the haemodynamics of iv paracetamol in neonates. Methods Retrospective, pooled analysis of heart rate (bpm) and blood pressure (mean, systolic, diastolic) observations collected during iv paracetamol pharmacokinetic studies in neonates. Heart rate and blood pressure were recorded just before and 30, 60, 120, 180, 240, 300 and 360 min after iv paracetamol (paired, ANOVA). Clinical characteristics in hypotensive (mean mmHg < gestational age, weeks) cases were compared with controls (Mann-Whitney U test). (21) bpm (paired p<0.05, ANOVA p=0.36). There were no changes in systolic and diastolic pressure, but mean arterial pressure decreased from 46 (7) to 43 (8) mmHg at 60 min (paired p <0.05, ANOVA p=0.75). Eight neonates developed hypotension. These patients had lower pre-administration arterial pressure (38 vs 47 mmHg, p<0.05). Conclusions In a setting of open label administration to alleviate (procedural) pain, haemodynamic effects of iv paracetamol in neonates remained modest. We suggest considering impaired haemodynamics to be a relative contra-indication for iv paracetamol in neonates.
Introduction
Paracetamol (acetaminophen) is the most frequently prescribed drug for pain or fever, even in neonates, and can be administered by an oral, rectal or intravenous (iv) route. An iv formulation likely improves prediction of concentration compared with enteral formulations by elimination of absorption variability. In recent years, data on iv paracetamol pharmacokinetics have been published [1] [2] [3] . In contrast, data on the pharmacodynamics of this formulation in neonates remain unreported.
De Maat et al. recently published their observations with iv paracetamol in adult medium and intensive care [4] . The authors illustrated that iv paracetamol affects haemodynamics (i.c. induces hypotension) in critically ill adults. They thereby confirmed other reports on haemodynamic (side) effects of this drug in critically ill adults [5] [6] [7] . Since clinical characteristics, co-morbidity and pharmacodynamics may be different in adults compared with neonates, we decided to quantify haemodynamics following iv paracetamol in neonates, based on pooled data analysis of observations collected during a reported pharmacokinetic study [1] and an ongoing study on pharmacokinetics and dynamics of iv paracetamol (PARANEO, NCT 00969176).
Methods

Available cohorts
Single-dose pharmacokinetic study in neonates
Neonates admitted within 24 h of birth and with an arterial line were included if propacetamol (Prodafalgan®; Bristol Myers Squibb, Braine l'Alleud, Belgium) was administered [1] . Propacetamol is an iv prodrug of paracetamol, but necessitates plasma esterase activity. This esterase function is already at an adult level of activity in early life [3] . Propacetamol was administered when neonates underwent minor, painful procedures (e.g. insertion of peripheral arterial or venous line, insertion of central venous line, placement of a chest tube) or as additional therapy in neonates on opioids. The decision to prescribe propacetamol or any other analgesic was made by the attending neonatologist. Exclusion criteria were major congenital malformations or birth asphyxia (Apgar <4 at 5 min). In this study, 30 patients were included. In the first 15 patients, 20 mg (equal to 10 mg paracetamol)/kg was administered, in the next 15 patients, 40 mg (equal to 20 mg paracetamol)/kg. Mean birth weight was 2,111 g (SD 1,094), mean gestational age (GA) was 33.8 weeks (SD 3.9). Mean postnatal age was 12.7 h (SD 6.4). Ten neonates were term, 20 were preterm (<37 weeks' GA), of whom 10 were <32 weeks' GA [1] .
Repeated dose PK/PD study
This is an interim analysis of an ongoing study on pharmacokinetics, -dynamics and safety of repeated iv paracetamol administration in the 42 neonates currently included (PARANEO, NCT 00969176, www.clinicaltrials.gov). Indications for initiation of iv paracetamol were medical or surgical painful conditions [8] . Mean weight was 2,580 g (SD 890), mean gestational age (GA) 35.5 weeks (SD 4.4), mean postnatal age 3 days (range 1-27). Twenty-two neonates were term, 20 preterm (<37 weeks' GA), of whom 4 were<32 weeks' GA. The primary outcome of this ongoing study are iv paracetamol pharmacokinetics, but pharmacodynamics-including haemodynamics-are also collected. The dosing regimen is based on a loading dose (20 mg/kg paracetamol), followed by an age-dependent maintenance dose (5 to 10 mg/kg/6 h) [2] .
Haemodynamics
Individual patient files were analysed for data on blood pressure (mean, systolic, diastolic [mmHg]) and heart rate (beats/min) from just before the first administration of iv paracetamol until 6 h after iv paracetamol administration. We hereby focussed on the haemodynamic effects of the first dose. Besides absolute values (mmHg), any mean arterial blood pressure < GA for a given GA (e.g. neonate of 30 weeks should have a mean arterial blood pressure of at least 30 mmHg) was recorded since this is the most frequently used "bedside" indicator of hypotension in neonates [8] . All observations are based on intra-arterial measurements.
Analysis and statistics
For statistical analysis, Medcalc® (Mariakerke, Belgium) was used. From the individual data, mean values and standard deviation were calculated when normal distribution was documented (Kolmogorov-Smirnov test); otherwise data are reported as median and range.
Baseline haemodynamics were recorded just before iv paracetamol administration. Correlations (Spearman's rank) between baseline values (heart rate, mean arterial blood pressure) and clinical characteristics (weight, age) were explored. Compared to baseline haemodynamics, changes in parameters up to 6 h after iv paracetamol were collected. From these individual data, mean values were calculated. Paired Wilcoxon's test was subsequently used to analyse changes compared with baseline (bpm, mmHg). One-way analysis of variance (ANOVA) was applied to test differences between the means of consecutive measurements. Finally, the incidence of hypotension was calculated, and characteristics of neonates who developed hypotension (any time) following iv paracetamol were compared with normotensive cases (Mann-Whitney U test).
Results
The pooled dataset consisted of haemodynamics in 72 patients and both preterm (n=40) and term (n=32) neonates were included. Baseline mean, systolic and diastolic blood pressure before iv paracetamol were 46 (SD 7), 55 (SD 10) and 38 (SD 7) mmHg, baseline heart rate was 145 (SD 20) (7) 45 (7) 43 (8) 45 (8) 44 (7) 45 (8) 45 (8) 45 (8) Systolic (mmHg) 55 (10) 52 (8) 51 (9) 53 (10) 51 (9) 53 (10) 51 (9) 52 (9) Diastolic (mmHg) 38 (7) 39 (7) 38 (8) 39 (8) 38 (7) 39 (8) 37 (7) 39 (8) bpm. Significant correlations between age and mean blood pressure (r=−0.39, p<0.01) or heart rate (r=0.28, p<0.05) were documented, reflecting the relative lower mean arterial pressure and higher heart rate in the smallest neonates.
Consecutive observations (mean, SD) on heart rate and mean, systolic and diastolic blood pressure are provided in Table 1 . There was a significant decrease (paired analysis) in heart rate 30 (−7 bpm), 60 (−4 bpm) and 120 (−8 bpm; all at least p<0.05) minutes following iv paracetamol with a subsequent trend towards normalisation, but still remaining significantly lower (all p<0.05) up to 360 min afterwards. Using ANOVA, there were no significant differences in the consecutive measurements (p=0.36). Mean arterial blood pressure displayed a minor, statistically significant decrease (−3 mmHg) at 60 min, with subsequent return to baseline values, without alterations in systolic or diastolic blood pressure. Similarly, there were no significant differences in mean arterial pressures using ANOVA (p=0.75).
Still, 18 observations in 8 (9 %) neonates were below the threshold of normal mean arterial blood pressure, defined as below the mmHg for the given age at inclusion. When clinical characteristics of hypotensive patients (n=8) were compared with those of normotensive patients (n=64), there was no significant difference in age (35 vs 36 weeks) or weight (2,455 vs 2,425 g), but baseline mean arterial pressure (38 vs 47 mmHg, p<0.05) was already lower in patients who subsequently developed hypotension. Baseline heart rate was not significantly different (154 vs 142 bpm).
Discussion
Based on prospectively collected observations in 72 neonates, we observed a modest clinical decrease in heart rate (7 bpm) and mean arterial blood pressure (3 mmHg) following iv paracetamol administration. A minority (9 %) developed hypotension. Interestingly, these neonates already had significantly lower blood pressure before paracetamol administration.
Effective management of pain should be based on systematic assessment of pain, followed by titrated administration of the most appropriated analgesic(s) with subsequent re-assessment. In any patient, the administration of an analgesic is a balanced decision based on perceived benefits (e.g. agitation, pain, stress) and risks (e.g. hypotension, bowel paresis, hypersensitivity, intolerance, withdrawal, neuro-apoptosis) [9] . When we focus on the haemodynamics of analgesics or sedatives in neonates, there are observations on the effect of midazolam (+30 bpm, −3 mmHg) [10] , fentanyl (−13 bpm, −3 mmHg) [11] , fentanyl and midazolam (−19 bpm, −12 mmHg) [12] , propofol (−9 bpm, −14 mmHg) [13] or morphine (−8 bpm, −3 mmHg) [14, 15] on heart rate and mean arterial blood pressure. Pre-existing low mean arterial pressure was a risk factor for subsequent hypotension following morphine administration [15] .
The present observations following iv paracetamol in neonates are likely the phenotypic result of both improved analgesia and procedural (initial indication for iv paracetamol)-related effects and one should take into account that paracetamol was administered unblinded and that the pooled analysis was retrospective. Taking these weaknesses into account, we suggest that-compared with other analgesics or sedatives-haemodynamic changes following iv paracetamol are limited, but not absent [11] [12] [13] [14] [15] [16] . It seems cautious to consider preadministrationimpaired haemodynamics a relative contra-indication to initiating iv paracetamol.
We can only speculate why the haemodynamics of iv paracetamol seem to be different in neonates [5, 7] . Hersch et al. [7] suggested that (traumatic) brain injury and pyrexia/hyperthermia might be risk factors, while de Maat et al. [5] were unable to unveil risk factors in medium-and intensive-care adult patients. However, it was illustrated that focussed studies on pharmacokinetics and -dynamics in neonates are relevant [16] .
